Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 1
3(60.0%)
Phase 2
2(40.0%)
5Total
Phase 1(3)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06996912Phase 2Active Not Recruiting

A Study for HSK44459 in Participants With Atopic Dermatitis

Role: lead

NCT06569784Phase 1Active Not Recruiting

Mass Balance Study of [14C]HSK31858 in Healthy Adult Male Chinese Subjects.

Role: lead

NCT06258746Phase 1Unknown

Pharmacokinetics, Mass Balance, and Metabolism of [14C]HSK31679 in Healthy Adult Male Volunteers.

Role: lead

NCT06314373Phase 1Recruiting

A Study for HSK39775 in Participants With Solid Tumors

Role: lead

NCT06290375Phase 2Not Yet Recruiting

A Study of HSK21542 in a Peritoneal Dialysis Pruritus Population.

Role: lead

All 5 trials loaded